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The Hippo transducers YAP/TAZ have been shown
to play positive, as well as negative, roles in Wnt
signaling, but the underlying mechanisms remain
unclear. Here, we provide biochemical, functional,
and genetic evidence that YAP and TAZ are integral
components of the b-catenin destruction complex
that serves as cytoplasmic sink for YAP/TAZ. In
Wnt-ON cells, YAP/TAZ are physically dislodged
from the destruction complex, allowing their nu-
clear accumulation and activation of Wnt/YAP/TAZ-
dependent biological effects. YAP/TAZ are required
for intestinal crypt overgrowth induced by APC defi-
ciency and for crypt regeneration ex vivo. InWnt-OFF
cells, YAP/TAZ are essential for b-TrCP recruitment
to the complex and b-catenin inactivation. In Wnt-
ON cells, release of YAP/TAZ from the complex is
instrumental for Wnt/b-catenin signaling. In line, the
b-catenin-dependent maintenance of ES cells in an
undifferentiated state is sustained by loss of YAP/
TAZ. This work reveals an unprecedented signaling
framework relevant for organ size control, regenera-
tion, and tumor suppression.
INTRODUCTION
Organ growth, tissue regeneration, and tissue replenishment are
remarkable processes requiring the concerted activation and
restriction of distinct gene-expression programs. How this is
achieved by just a handful of signaling cascades is a central
question in cell biology. Wnt growth factors play prominent
and pleiotropic roles in cell-cell communication, including con-
trol of cell fate, proliferation, and stem cell maintenance. A
main effector of Wnt signaling is nuclear b-catenin, which regu-
lates the transcription of Wnt target genes by binding to TCF/
Lef transcription factors (Clevers, 2006). The core of the Wntpathway is the regulation of b-catenin by a cytoplasmic destruc-
tion complex consisting of a central scaffold protein, Axin, that
interacts with other factors, such as adenomatous polyposis
coli (APC), glycogen synthase kinase-3 (GSK3) and casein
kinase 1 (CK1). In the absence of Wnt signaling, the destruction
complex efficiently captures cytosolic b-catenin, leading to its
phosphorylation by GSK3 and degradation by the b-TrCP ubiq-
uitin ligase. Wnt causes functional inactivation of the destruction
complex, with ensuing escape of b-catenin from degradation, re-
sulting into b-catenin accumulation and nuclear entry (Clevers,
2006; Taelman et al., 2010). The mechanisms by which Wnt in-
hibits the destruction complex are only partially understood,
but recent work indicated that a key step regulated by Wnt is
the dissociation of b-TrCP from the complex (Li et al., 2012).
How this step takes place remains unknown.
Independent of these findings, a large body of work has iden-
tified YAP and TAZ as pivotal regulators of cell proliferation and
‘‘stemness,’’ particularly during organ growth, regeneration, and
tumorigenesis (Piccolo et al., 2013). YAP and TAZ are closely
related proteins, well known for being nuclear effectors of the
Hippo signaling cascade and of mechanical cues (Pan, 2010).
The overlap between the biological processes governed by
YAP/TAZ and Wnt/b-catenin hints that these factors do not
work in isolation and may influence each other’s activity. In
fact, we recently reported a direct biochemical connection:
phosphorylated b-catenin promotes TAZ degradation by serving
as presenting factor for TAZ to b-TrCP (Azzolin et al., 2012). By
controlling b-catenin stability, Wnt also induces TAZ stabilization
and TAZ nuclear entry in a manner independent of Hippo
signaling (Azzolin et al., 2012). By comparison, YAP stability is
unaffected by Wnt, and yet, during our subsequent investiga-
tions, we found thatWnt signaling also regulates YAP by promot-
ing its nuclear accumulation (as described in the Results section
below). These data clearly hinted to the existence of unknown
mechanisms by which YAP/TAZ are integrated with the Wnt
pathway.
While we studied TAZ regulation by b-catenin, others looked in
reciprocal direction and found that Hippo signaling regulates
b-catenin but also that YAP/TAZ inhibits Wnt/b-catenin signalingCell 158, 157–170, July 3, 2014 ª2014 Elsevier Inc. 157
(Heallen et al., 2011; Imajo et al., 2012; Varelas et al., 2010). For
example, genetic knockout of Hippo pathway components in the
heart causes concomitant nuclear accumulations of YAP/TAZ
and b-catenin, with b-catenin being genetically required down-
stream of Hippo for organ overgrowth (Heallen et al., 2011).
How to make sense of these disparate observations? Upon
reflection, we realized that all the available evidence could be
explained by a simple scenario in which cytoplasmic YAP/TAZ
are integral factors of the destruction complex. In this hypo-
thesis, cells without Wnt would, at once, sequester YAP/TAZ
to the destruction complex and use them to degrade b-catenin.
Wnt stimulation would then eliminate, or inhibit, cytoplasmic
YAP/TAZ, causing b-catenin stabilization, as well as YAP/TAZ
nuclear accumulation. Here, we have validated this hypothesis
at the biochemical, functional, and genetic levels.
RESULTS
YAP/TAZ Are Transcriptionally Inactivated by
Sequestration in the Destruction Complex
HEK293 cells carry a functional destruction complex. We sought
to determine whether YAP/TAZ are constituents of the destruc-
tion complex. Axin1 serves as scaffold for all the other known
components of the destruction complex, and, owing to its very
low abundance, it also represents a rate-limiting factor for com-
plex activity (Li et al., 2012). We thus probed the endogenous
protein composition of the destruction complex in Wnt OFF cells
by carrying out immunoprecipitations for endogenous Axin1.
Associated proteins were detected by western blotting. This
analysis revealed that Axin1 not only bound established ele-
ments of the destruction complex (such as GSK3b, b-catenin
and b-TrCP) but, remarkably, also strongly associated to endo-
genous YAP and TAZ (Figure 1A). To further confirm YAP/TAZ
association to the destruction complex, we carried out immuno-
precipitations for endogenous YAP/TAZ from extracts of control
or Axin1/2-depleted HEK293 cells. As shown in Figure 1B, YAP
and TAZ associate with endogenous Axin1, b-catenin, GSK3,
and b-TrCP. Axin1/2 knockdown abolishes YAP/TAZ interaction
with b-catenin, GSK3, and b-TrCP, demonstrating that these
proteins are part of the same Axin-based protein complexes.
The interaction of Axin1 with YAP/TAZ was confirmed with
epitope-tagged proteins (Figure S1B [available online] and data
not shown) and occurs independently from the WW domain of
YAP (Figure S1C). Moreover, the binding between Axin1 and
YAP/TAZ appears direct, as it could be recapitulated in vitro
using recombinant proteins (Figure 1C). Taken together, the
data support the view that, in the Wnt OFF condition, YAP/TAZ
associated to the destruction complex via interaction with Axin.
What is the relevance of these biochemical interactions for
YAP/TAZ function? A hallmark of YAP/TAZ regulation is inhibi-
tion of their transcriptional responses through cytoplasmic
sequestration. The molecular nature of the cytoplasmic anchors
for YAP/TAZ is incompletely understood. For example, phos-
phorylation of YAP S127 by the Hippo kinase LATS creates a
binding consensus for 14-3-3 proteins that are thought to
contribute to retain YAP/TAZ in the cytoplasm (Pan, 2010). This
model is, however, not entirely coherent with some recent
experimental observations suggesting that YAP phosphorylation158 Cell 158, 157–170, July 3, 2014 ª2014 Elsevier Inc.is not the major determinant of YAP subcellular localization
(Barry et al., 2013; Dupont et al., 2011); this suggests the exis-
tence of other, yet unknown, mechanisms for YAP/TAZ seques-
tration in the cytoplasm. In light of the biochemical interactions
shown in Figures 1A–1C, we hypothesized that the destruction
complex might indeed represent a cytoplasmic anchor for
YAP/TAZ (see scheme in Figure 1D). To test this hypothesis,
we carried out Axin1/2 or APC knockdowns and found that this
led to a remarkable nuclear accumulation of YAP and TAZ (Fig-
ures 1E and S1D) with YAP/TAZ-dependent induction of their
transcriptional target CTGF (Figures 1F, S1E, and S1F). Thus,
YAP/TAZ incorporation in the destruction complex favors YAP/
TAZ cytoplasmic sequestration in Wnt-OFF cells.
Wnt Releases YAP/TAZ from the Complex
The destruction complex is at the centerpiece of Wnt pathway
regulation, and Wnt signals through inactivation of the destruc-
tion complex (Clevers, 2006). We thus monitored the effect of
purified Wnt3A ligand on the subcellular localization of endo-
genous YAP by immunofluorescence in various cell types
(HEK293, ST-2 mesenchymal stem cells, and P19 embryonic
carcinoma cells). YAP was mostly cytoplasmic in confluent, un-
treated cells (Figures 2A and 2B and data not shown) but mark-
edly relocalized in the nucleus afterWnt treatment. This occurred
in absence of any effect on YAP protein stabilization (Figure S2A
and data not shown). As expected from our previous report
(Azzolin et al., 2012), TAZ protein was stabilized byWnt signaling
(Figure S2A) and, similarly to YAP, TAZ was also relocalized in
the nucleus by treatment with Wnt3A (Figure S2B). Wnt-induced
YAP/TAZ nuclear localization was paralleled by transcriptional
activation of the synthetic TEAD reporter (8xGTIIC-Lux) and of
the direct YAP/TAZ target genes Cyr61 and Ankrd1 (Figures
2C, 2D, S2C, and S2D). Of note, YAP/TAZ nuclear accumulation
and activation of the TEAD reporter could be detected as early as
30 min after Wnt stimulation, a timing comparable to first detect-
able induction of the TCF/b-catenin reporter TOP-FLASH (Fig-
ure 2E and data not shown).
The above results raise questions on how Wnt signaling
impacts YAP/TAZ subcellular localization. It is well known that
the destruction complex is recruited to Wnt-activated Fz-LRP6
receptors through Axin/LRP6 interactions (Clevers, 2006). This
prompted us to investigate the effects of Wnt3A stimulation on
the interaction between Axin1 and YAP/TAZ. Confirming prior
reports (Li et al., 2012; Willert et al., 1999), after Wnt treatments
(t = 0.5, 2, and 4 hr), Axin1 was recruited to LRP6without causing
any modifications in complex composition when we considered
the canonical components of the Wnt cascade (GSK3b, b-cate-
nin, and Dishevelled; Figure 2F and data not shown). Strikingly,
however, we found that Wnt stimulation changes the molecular
composition of the complex in relation to YAP/TAZ; their associ-
ation with Axin1 rapidly decreases and becomes undetectable
after 30 min (TAZ) or at 2 hr (YAP) from Wnt3A addition (Fig-
ure 2F). Consistent results were obtained by immunoprecipita-
tion of Axin1 from lysates of Wnt-treated P19 cells (Figure S2F).
Intriguingly, we noticed that the progressive dissociation of
YAP/TAZ from Axin paralleled the increased association of
Axin1 to LRP6 (Figure 2F). These results are compatible with
a scenario in which the binding of YAP/TAZ to Axin1 is
Figure 1. YAP and TAZ Are Part of the b-Catenin Destruction Complex
(A) Western blot of endogenous proteins coimmunoprecipitating with endogenous Axin1 (IP) from HEK293 cell extracts. Lysates from Axin1-depleted cells were
used as specificity control of the anti-Axin1 antibody. See Figure S1A for IP inputs.
(B) Western blot of endogenous proteins coimmunoprecipitating with endogenous YAP/TAZ from HEK293 cell extracts. siYAP/TAZ (siY/T#1) provides specificity
control.
(C) Autoradiography of in-vitro-translated 35S-Axin1 pulled down by GST-YAP or GST-TAZ, immobilized on a glutathione-resin. GST protein was used as a
negative control. Input: fraction of 35S-Axin1 used for the pull-down experiments.
(D) Schematic prediction of the effects of Axin depletion on YAP/TAZ localization and activity.
(E) Representative confocal images of YAP in MII cells transfected with the indicated siRNAs. Scale bar, 20 mm.
(F) qRT-PCR for YAP/TAZ target gene CTGF, normalized toGAPDH expression, in MII cells transfected as in (E), in combination with control or YAP/TAZ siRNAs
as indicated. Data are normalized to control siRNA-treated cells and presented as mean + SD.
See also Figure S1.outcompeted by LRP6, causing YAP/TAZ to be released from
the complex (Figure 2G). To test this hypothesis, we carried
out structure-function studies by GST pull-down assays and
assayed distinct C-terminal deletions of Axin1 for ability to
interact with recombinant YAP. As schematized in Figure 2H,
YAP binds to Axin1 in the same domain that Axin1 uses to
dock LRP6 (Mao et al., 2001). This conclusion was corroborated
by coimmunoprecipitation experiments of HEK293 cell lysates
transfected with Flag-YAP and Myc-tagged Axin1 deletion con-
structs (Figure S2H).
If, in Wnt-ON cells, LRP6 releases YAP/TAZ from the destruc-
tion complex by displacing them fromAxin1, then experimentally
raising the doses of LRP6 should titrate Axin1 away from
interacting with YAP/TAZ. To test this prediction, HEK293 were
transfected with a fixed amount of Axin1 and YAP expressionplasmids, together with increasing doses of plasmids encoding
for LRP6 (Figure 2I). Lysates were immunoprecipitated with
anti-Axin antibodies and coprecipitating YAP and LRP6 de-
tected bywestern blotting. As shown in Figure 2I, YAP is robustly
coimmunoprecipitated with Axin1 in the absence of LRP6
(lane 2). In contrast, increasing levels of LRP6 progressively
dislodge YAP from Axin1 (Figure 2I, lanes 3–5). In line, trans-
fected LRP6 dose-dependently induces the 8xGTIIC-Lux re-
porter in a YAP/TAZ-dependent manner in both HEK293 and
P19 cells (Figures 2J and S2J); moreover, LRP6 overexpression
in stably transfected MII cells also turns on the YAP/TAZ endo-
genous targets Axl, CTGF, Cyr61, and Ankrd1 (Figure S2K). We
conclude from this set of experiments that, in Wnt OFF cells,
the destruction complex is a cytoplasmic sink for YAP/TAZ
and that Wnt treatment dislodges YAP/TAZ from the destructionCell 158, 157–170, July 3, 2014 ª2014 Elsevier Inc. 159
Figure 2. Wnt Releases YAP and TAZ from the Destruction Complex
(A and B) Confluent HEK293 cells (A) or ST-2 cells (B) were treated with Wnt3A ligand or left untreated. After 8 hr, cells were fixed for immunofluorescence with
anti-YAP-specific antibody. Scale bars, 20 mm in (A) or 40 mm in (B).
(C) HEK293 cells were transfected with control (lanes 1 and 2) or two independent YAP/TAZ (lanes 3 and 4) siRNAs and either left untreated (lane 1) or treated with
Wnt3A (lanes 2–4). The panel represents the results of luciferase assays with the 8xGTIIC-Lux reporter, recording YAP/TAZ-dependent transcriptional activity.
Data are normalized to lane 1 and are presented as mean + SD.
(D) ST-2 cells were transfected with control (lanes 1 and 2) or two independent YAP/TAZ (lanes 3 and 4) siRNAs and either left untreated (lane 1) or exposed to
Wnt3A (lanes 2–4). The panel represents qRT-PCR for YAP/TAZ target gene Cyr61, relative toGapdh expression. Data are normalized to lane 1 and presented as
mean + SD.
(E) Wnt3A-induced activation of TOP-FLASH or 8xGTIIC-Lux reporters was examined at different time points. Data are presented as average fold induction
relative to time 0 ± SD.
(F) HEK293 cells were treated with Wnt3A and harvested at different time points as indicated. Lysates were subjected to IP using an anti-Axin1 antibody or rabbit
IgG as control. Coprecipitating proteins were visualized by western blot. See also Figure S2E for IP inputs.
(G) Scheme on how Wnt promotes YAP/TAZ nuclear localization.
(legend continued on next page)
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complex, causing induction of TEAD-mediated transcription.
Inactivation of the destruction complex by loss of complex com-
ponents or Wnt stimulation releases YAP/TAZ and causes their
nuclear accumulation with induction of YAP/TAZ transcriptional
responses (see Figure 2G for a scheme).
A Genetic Link between YAP/TAZ and Intestinal Crypt
Growth Driven by Wnt Signaling
Next, we sought to determine the biological relevance of YAP/
TAZ regulation by the Wnt destruction complex. The intestinal
epithelium has been extensively used as model to study Wnt-
driven tissue homeostasis and regeneration (Clevers, 2006).
Wnt signaling is active on all crypt cells—including intestinal
stem cells devoted to normal replenishment of the intestinal
tissue—but inactive in villi. Moreover, Wnt signaling has been
shown to be instrumental for the in vitro regeneration of crypt-
like structures, or crypt organoids, and for epithelial repair in vivo
(Ashton et al., 2010; Cordero and Sansom, 2012; de Lau et al.,
2011). Crucially, the destruction complex component APC is
the main intestinal tumor suppressor, being inactivated in the
large majority of hereditary and sporadic forms of human colo-
rectal cancers (Clevers, 2006). In mouse models bearing condi-
tional Apcfl/fl alleles, acute activation of the Wnt cascade in the
intestinal epithelium causes massive hyperplasia with perturbed
differentiation (Sansom et al., 2004).
With this background in mind, we first monitored the expres-
sion of endogenous YAP and TAZ by western blotting in
dissected crypts and villi. As shown in Figure 3A, both YAP
and TAZ are specifically expressed in the crypt compartment
(compare lanes 1 and 2); this most likely reflects a posttranscrip-
tional regulation, as we could not detect any differences in
mRNA levels between crypts and villi (Figure S3A). These results
are consistent with a recent report on YAP immunolocalization in
the stem cells of the crypt base (Barry et al., 2013). By compar-
ison, we found that TAZ protein has a broader expression in the
nuclei of all crypt cells, with the exception of Paneth cells (Fig-
ures S3B and S3C). Thus, YAP/TAZ nuclear localization in a large
fraction of crypt cells is at least consistent with their proposed
regulation by endogenous Wnt signals. In line with this conclu-
sion, YAP and TAZ proteins become ectopically stabilized in villi
after intestinal-specific knockout of APC (i.e., after tamoxifen
treatment of Villin-CreERT2; Apcfl/fl mice; Figure 3A, compare
lanes 2 and 4).
To genetically address the relevance of YAP/TAZ as down-
stream effectors of Wnt signaling in the mouse small intestine,
we compared the effect of acute activation of the pathway
induced by APC inactivation in the absence or presence of
concomitant genetic ablation of both YAP and TAZ. For this,
we generated combined APC, TAZ, and YAP conditional
alleles under the control of Villin-CreERT2 (Villin-CreERT2; Apcfl/fl;(H) Panels show the summary of pull-down experiments using full-length YAP an
the Dishevelled (Dix), LRP5/6 (LRP), b-catenin (bcat), and GSK3 (GSK)-binding d
(I) Binding of Axin1 to LRP6 is alternative to Axin1-YAP interaction. HEK293 cells w
amount of HA-LRP6 as indicated, and lysates were subjected to anti-Myc IP. Se
(J) Luciferase assay on 8xGTIIC-Lux reporter in HEK293 cells transfected with inc
siRNAs. Graphs are mean ± SD.
See also Figure S2.Yapfl/fl; Tazfl/fl). Adult mice were injected with tamoxifen and
initially sacrificed after 3 days, a time point when Villin-CreER-
T2;Apcfl/fl mice became moribund. Strikingly, the gross changes
associated with inactivation of APC—such as massive crypt
hyperplasia, increased number of Ki67 positive/proliferating
cells, and loss of enterocyte differentiation—were absent in the
triple mutant mucosae that appeared histologically comparable
to those of wild-type animals (Figures 3B and 3C). This was re-
flected by a rescue of survival, as all the triple mutant mice
were still alive and not showing any sign of aberrant crypt hyper-
plasia after 3 weeks, the endpoint of our experiment (Figures 3B
and 3C). We confirmed that our tamoxifen-induced recombina-
tion protocol produced APC and YAP/TAZ mutant crypts by
genomic PCR on dissected crypts (Figure S3F). Importantly,
the b-catenin targets LEF-1 and CD44 remained expressed at
elevated levels and ectopically throughout the crypt-villus axis
in triple mutant mice (Figure 3A, compare lanes 3 and 4 with
lanes 5 and 6), indicating that ablation of YAP/TAZ does not
modify ectopic b-catenin activity induced by the APC mutation.
Single depletion of YAP or TAZ was not sufficient to oppose APC
inactivation, as APC/YAP or APC/TAZmutant mice died only few
days after those carrying the sole APC inactivation and with the
typical intestinal phenotype associated to APC deficiency (data
not shown).
Individual and double deficiency of YAP and TAZ has little
consequences on proliferation of crypt cells and,more generally,
on intestinal architecture, suggesting that YAP/TAZ are largely
dispensable for intestinal homeostasis (data not shown). The
results thus suggest a scenario in which YAP/TAZ transcriptional
effects are required for a segment of Wnt responses, such as
those caused by Wnt hyperactivation following loss of the
destruction complex (see Discussion). The processes that drive
hyperplasia in the context of APC deficiency are considered
highly analogous to those driving intestinal regeneration after
damage (Cordero and Sansom, 2012; Ashton et al., 2010).
With this in mind, we sought to assess the combined relevance
of YAP and TAZ for Wnt-dependent responses related to crypt
regeneration. For this, we focused on the growth of explanted
intestinal crypts into budding organoids, as this represents a
well-defined experimental system that requires Wnt signaling
and is reminiscent of in vivo regeneration (de Lau et al., 2011).
Crypts were explanted from control Villin-CreERT2 mice or
from mice carrying double YAP/TAZ conditional alleles (Villin-
CreERT2; Yapfl/fl; Tazfl/fl) and then seeded in Matrigel with a cock-
tails of supplements, including the Wnt-agonist R-Spondin,
which is essential for crypt maintenance and growth (Sato
et al., 2009). Control explants formed organoids in the presence
or absence of tamoxifen. Remarkably, tamoxifen-induced
combined deletion of YAP/TAZ blocked crypt growth and led
to the demise of the mutant crypts, revealing the essential roled the indicated C-terminal deletion constructs of Axin1, progressively deleting
omains, as depicted on the left.
ere transfected with limiting amount ofMyc-Axin1 and Flag-YAP and increasing
e Figure S2I for inputs.
reasing doses of LRP6-expressing vector and either control, YAP, or YAP/TAZ
Cell 158, 157–170, July 3, 2014 ª2014 Elsevier Inc. 161
Figure 3. YAP and TAZ Are Required for Wnt-Driven Biological Effects in the Mouse Small Intestine
(A) Mice of the genotypes Villin-CreERT2 (control, lanes 1–2), Villin-CreERT2; Apcfl/fl (lanes 3–4), and Villin-CreERT2; Apcfl/fl Yapfl/fl; Tazfl/fl (lanes 5–8) were injected
with tamoxifen. After 3 or 21 days, intestinal crypts and villi were explanted, and lysates were subjected to western blot analysis for YAP, TAZ, and E-cadherin and
for the b-catenin targets LEF-1 and CD44. See Figures S3D and S3E for generation and validation of Taz conditional knockout mice.
(B and C) Loss of APC induces crypt expansion associated with rapid demise of the animals, and these phenotypes are rescued by concomitant deletion of YAP/
TAZ. (B) Kaplan-Meyer survival graphs of mice with the indicated genotypes after tamoxifen injection. Log rank test p value < 104. (C) Panels are representative
(legend continued on next page)
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of YAP/TAZ in these processes (Figures 3D and 3E). This pheno-
type is reminiscent of combined knockout of the R-Spondin
receptors LGR4/5 (de Lau et al., 2011) and reinforces the notion
that YAP/TAZ are required for a relevant set ofWnt responses. Of
note, individual knockout of TAZ or YAP remains largely compat-
ible with organoid formation, indicating a functional redundancy
between these factors (Figure S3I).
In the Complex, YAP/TAZ Recruits b-TrCP for b-Catenin
Degradation
Data presented so far provide strong biochemical and biological
evidence that the destruction complex is a cytoplasmic sink for
YAP/TAZ. We next decided to change point of view and asked
the following question: does YAP/TAZ incorporation affect the
most established function of the destruction complex, that is,
b-catenin inhibition in Wnt OFF cells? The cytoplasmic pool of
b-catenin is constantly degraded through recruitment of the E3
ubiquitin ligase b-TrCP in the destruction complex (Clevers,
2006; Li et al., 2012). To determine the role of YAP/TAZ in these
processes, we carried out knockdowns of YAP/TAZ in HEK293
with independent pairs of siRNAs. Lysates from these cells (Fig-
ure S4) were immunoprecipitated with anti-Axin1 antibodies and
analyzed bywestern blotting. As shown in Figure 4A, depletion of
YAP/TAZ has no effect on the interaction between Axin1, GSK3,
or b-catenin but dramatically impeded b-TrCP association with
the complex. Together, this indicates that b-catenin phosphory-
lation is by itself insufficient for b-TrCP binding, as YAP/TAZ are
required for docking b-TrCP to the destruction complex (Fig-
ure 4B). Notably, depletion of YAP/TAZ phenocopies Axin1/2
knockdown or Wnt3A stimulation, leading to a robust and b-cat-
enin-dependent activation of the TOP-FLASH reporter (Fig-
ure 4C). That said, b-catenin inhibition by YAP/TAZ still requires
the well-documented b-catenin phosphorylation by GSK3, as a
version of b-catenin mutated in its GSK3 sites escapes YAP/
TAZ control (Figure 4D). Collectively, the data indicate that the
control of b-catenin in Wnt OFF cells is mediated by the conver-
gence of two mechanisms: phosphorylation of b-catenin by
GSK3 and b-TrCP docking to the destruction complex via
YAP/TAZ (Figure 4B).
By Releasing YAP/TAZ, Wnt Blocks the Recruitment of
b-TrCP to the Complex
The results also link to howWnt inhibits the destruction complex.
We investigated the composition of the Axin1 complex in Wnt
ON cells and found that Wnt stimulation macroscopically inhibits
b-TrCP recognition. This cannot be explained by reduced b-cat-
enin phosphorylation: within the complex, the levels of the un-
phosphorylated b-catenin are actually reduced, indicating that
GSK3 remains active on bound b-catenin (Figure 4E). These
results are consistent with a recent paper by Clevers and col-immunohistochemical stainings of the small intestine for the proliferation marke
injection.
(D and E) YAP and TAZ are required for survival of explanted intestinal crypts. (D
CreERT2 and Villin-CreERT2; Yapfl/fl; Tazfl/fl and cultured ex vivo for 3 days. Wher
ure S3G for representative pictures of explanted crypts a few hours after seeding
depicted in (D). See Figure S3H for PCR controls of genomic recombination.
See also Figure S3.leagues (Li et al., 2012) that reported similar observations. How-
ever, how b-TrCP fails to be recruited to the destruction complex
in Wnt ON cells is unknown. We noticed that, after addition of
Wnt, b-TrCP dissociation from Axin1 occurred concomitantly
to YAP/TAZ dissociation (Figure 4E). Because YAP/TAZ are
essential for b-TrCP association to the complex in Wnt OFF cells
(Figure 4A), the data suggest that Wnt/LRP6 impedes b-TrCP
recognition simply by displacing YAP and TAZ from Axin. If so,
raising YAP protein levels should allow the destruction complex
to ‘‘resist’’ inhibition by Wnt/LRP6 signaling. To test this, we ex-
pressed increasing levels of wild-type YAP in HEK293 cells and
monitored b-catenin/TCF-dependent activation with the TOP-
FLASH reporter induced by cotransfected LRP6 or by Wnt
treatment. As shown in Figures 5A and 5B, gain-of-YAP effec-
tively inhibits canonical Wnt signaling in a concentration-depen-
dent manner. Consistent results were obtained bymeasuring the
expression of the b-catenin endogenous target Axin2 (Figures
S5B and S5C). As control, the same doses of YAP were largely
ineffective in cells in which b-catenin activation was triggered
by Axin1/2 knockdown (Figure 5C) or in APC mutant colorectal
cancer cells SW480 (Figure S5D), results that are consistent
with YAP operating at the level of the destruction complex.
We then sought to demonstrate that the functional inhibition
of Wnt/b-catenin signaling by YAP is underlined by a sustained
association of YAP to the destruction complex. For this,
HEK293 cells were transfected with limiting amounts of Axin1
and LRP6 expression vectors in the presence of increasing
amounts of YAP. As shown in Figure 5D, Axin1 immunoprecipita-
tion indeed demonstrated that LRP6/Axin1 complex formation is
first weakened and then lost at increasing doses of YAP; in line,
YAP binding to Axin1 is inversely correlated to LRP6/Axin1 asso-
ciation (Figure 5D). Next, we analyzed how sustained YAP levels
affect the composition of the endogenous destruction complex in
Wnt-ON cells. Immunoprecipitation of endogenous Axin1 from
YAP-expressing and Wnt3A-treated cells revealed that over-
expressed YAP sustained b-TrCP association (Figure 5E). As
such, YAP effectively sustains a ‘‘Wnt-OFF-like’’/b-TrCP-bound
complex composition opposing the effect of Wnt stimulation.
Cytoplasmic, but Not Nuclear, YAP/TAZ Are b-Catenin
Inhibitors: Role in Mouse ES Cells
The data presented so far strongly suggest that cytoplasmic
YAP/TAZ are integral components of the destruction complex.
The corollary of this conclusion is that any YAP/TAZ regulatory
input that diverts YAP/TAZ to the nucleus away from the destruc-
tion complex would phenocopy, prime, or sustain Wnt/b-catenin
signaling; vice versa, any YAP/TAZ regulation that would favor
cytoplasmic retention of YAP/TAZ would also favor the activity
of the destruction complex and inhibit Wnt/b-catenin signaling.
To provide a proof of principle of this notion, we carried outr Ki-67 of mice with the indicated genotypes at day 3 or 21 after tamoxifen
) Representative images of organoids formed by crypts explanted from Villin-
e indicated, tamoxifen was added to the culture medium at seeding. See Fig-
. (E) Quantification of the number of organoids formed by each of the samples
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Figure 4. YAP and TAZ Recruit b-TrCP to the Complex
(A) Loss of YAP/TAZ decreases the amount of b-TrCP associated with the Axin1 complex. HEK293 cells were transfected with two independent control (lanes 2
and 3) or two independent YAP/TAZ (lanes 4 and 5) siRNAs. Lysates were then subjected to IP using an anti-Axin1 antibody, and coprecipitating endogenous
proteins were detected by western blot. Lysates from Axin1-depleted cells (lane 1) were used as specificity control. See Figure S4 for IP inputs.
(B) Scheme of our experimental hypothesis for the experiments described in (C) and (D).
(C) Luciferase assay using the TOP-FLASH reporter in HEK293 cells transfected with control or two independent YAP/TAZ siRNAs, compared to the effect of
Axin1/2 siRNA or Wnt3A stimulation. Bars are mean + SD. Inductions are b-catenin dependent.
(D) HEK293 cells were transfectedwith TOP-FLASH together with control (blue bars) or two independent YAP/TAZ (gray bars) siRNAs. Lane 1: YAP/TAZ depletion
activates TOP-FLASH reporter. Lane 2: knockdown of endogenous b-catenin abolishes the effects of YAP/TAZ depletion. Lanes 3 and 4: cells were transfected
with b-catenin siRNA and reconstituted with either wild-type (WT) or phosphomutant (S/A) siRNA-insensitive b-catenin. The basal activity of WT b-catenin is
enhanced by YAP/TAZ depletion (lane 3), whereas S/A b-catenin displays a higher basal activity that is not further increased by YAP/TAZ knockdown.
(E) HEK293 cells were treated with Wnt3A and harvested at different time points as indicated. Lysates were subjected to IP using an anti-Axin1 or rabbit IgG
antibodies, and coprecipitating proteins were detected by western blot.
See also Figure S4.two sets of experiments. First, we demonstrated that LRP6-
mediated activation of the TOP-FLASH reporter is inhibited
by wild-type YAP (a prevalently cytoplasmic protein, data not
shown), but not by a version of YAP forced to the nucleus by car-
rying an exogenous nuclear localization signal (NLS) (Figure 5F).
Second, we considered a main mechanism by which YAP/TAZ
are normally retained in the nucleus, that is, inactivation of the
Hippo pathway leading to nuclear YAP/TAZ associated with
TEAD (Pan, 2010). This can be mimicked by expression of
YAP-5SA or TAZ-4SA variants, bearing mutations that do not
allow LATS phosphorylation, and are typically localized to the
nucleus (Pan, 2010). Indeed, when we depleted endogenous164 Cell 158, 157–170, July 3, 2014 ª2014 Elsevier Inc.YAP/TAZ by small interfering RNAs (siRNAs) and then replen-
ished cells with either wild-type YAP or YAP-5SA, only wild-
type YAP restored b-catenin inhibition, as measured with the
TOP-FLASH reporter (Figure 5G, compare lanes 3 and 4). Similar
results were obtained by comparing TAZ wild-type versus TAZ-
4SA (Figure 5G, compare lanes 5 and 6).
We next aimed to demonstrate the relevance of YAP/TAZ for
b-catenin inhibition on relevant biological effects controlled by
b-catenin/TCF beyond the monitoring of b-catenin activity with
the TOP-FLASH reporter. In pondering these experiments, we
excluded Wnt-dependent phenotypes requiring both YAP/TAZ
and b-catenin/TCF transcriptional programs; we reasoned that,
Figure 5. Cytoplasmic YAP/TAZ Inhibit b-Catenin at the Level of the Destruction Complex
(A) Luciferase assay with the TOP-FLASH reporter in HEK293 cells transfected with empty vector or LRP6-expressing plasmid and increasing amount of YAP-
encoding plasmid. Data are normalized to empty vector-transfected cells, and graphs are mean ± SD. See Figure S5A for controls.
(B) TOP-FLASH reporter assays in cells transfected with increasing amount of a wild-type YAP-encoding plasmid and either treated with Wnt3A or left untreated.
Data are normalized to untreated cells, and graphs are mean ± SD.
(C) TOP-FLASH reporter assays in cells transfected with control or Axin1/2 siRNAs and increasing amount of a wild-type YAP-encoding plasmid. Data are
normalized to empty vector-transfected cells, and graphs are mean ± SD.
(D) HEK293 cells were transfected with limiting amount of Myc-Axin1 and HA-LRP6 and increasing amount of Flag-YAP, as indicated, and lysates were subjected
to anti-Myc IP. See Figure S5E for IP inputs.
(E) HEK293 cells were transfectedwith empty vector (left) or YAP-encoding plasmid (right), treatedwithWnt3A and harvested at different time points as indicated.
Lysates were subjected to IP using an anti-Axin1 antibody or rabbit IgG as control. Coprecipitating proteins were visualized by western blot. See Figure S5F for IP
inputs.
(F) Nuclear YAP is ineffective at inhibiting b-catenin. HEK293 cells were transfected with empty vector, HA-LRP6, HA-tagged wild-type, and constitutive nuclear
(NLS) YAP, as indicated. Top: TOP-FLASH reporter assays. Data are normalized to lane 1, and bars are mean + SD. Bottom: western blot for transfected proteins.
See Figure S5G for controls.
(G) The panel represents the results of luciferase assay with the TOP-FLASH reporter in cells transfected with control (lane 1) or YAP/TAZ (lanes 2–6) siRNAs and
reconstitutedwith either wild-type (lane 3) or LATS-insensitiveYAP (5SA, lane 4) or with either wild-type (lane 5) or LATS-insensitive TAZ (4SA, lane 6). Lane 1 versus
2: depletionof YAP/TAZactivates the TOP-FLASH reporter. Lanes 3 and5: reconstitutionwith siRNA-insensitivewild-typeYAPorwild-typeTAZ rescues this effect,
demonstrating that bothYAPandTAZcan function asb-catenin inhibitors. Lanes 4 and6: reconstitutionswith siRNA-insensitiveYAP5SAor TAZ4SAare ineffective.
See also Figure S5.in these cases, the consequences of losing nuclear YAP/TAZ
functions would be dominant, preventing any assessment of
the role of cytoplasmic YAP/TAZ as b-catenin inhibitors. Thus,
we focused on mouse embryonic stem (ES) cells, as these can
be propagated in an undifferentiated and pluripotent state
when cultured in the fully defined ‘‘2i’’ medium consisting of
serum-free medium supplemented with two inhibitors targeting
MEK and GSK3 (‘‘PD’’: PD0325901 and ‘‘CH’’: CHIR99021,
respectively) (Ying et al., 2008). In these conditions (Figure 6A),
b-catenin-dependent transcriptional responses are required for
ES cell maintenance: genetic ablation of b-catenin or omissionof the GSK3 inhibitor from the medium (i.e., ‘‘PD-only’’ medium,
corresponding to GSK3-ON and nuclear b-catenin-OFF) both
lead to loss of self-renewal and activation of differentiation, as
previously reported (Wray et al., 2011).
Importantly, through an unrelated research line in our labora-
tory, we had discovered that quantitative YAP/TAZ depletion
by independent siRNA pairs is inconsequential for ES cell prop-
agation in the 2i medium (Figure S6A and see below). For
example, depletion of YAP and TAZ has no effect on the Rex1-
GFPd2 ES cells (Figure S6B), which express an unstable form
of GFP driven by endogenous Rex1 locus, a gene expressedCell 158, 157–170, July 3, 2014 ª2014 Elsevier Inc. 165
Figure 6. Loss of YAP/TAZ Compensates for Lack of Wnt Signaling, Opposing Differentiation of ES Cells
(A) Colony-forming assay onb-catenin fl/ (i.e., heterozygouscontrol) andb-cateninD/ (i.e., null) ES cells. Cellswere plated at clonal density in 2imediumor in the
presence of the sole PD. After 5 days, cells were stained for alkaline phosphatase (AP). Columns show the number of AP-positive colonies. Bars are mean + SD.
(B) Loss of YAP/TAZ can substitute CH in preserving ES cells in an undifferentiated state. Panels are representative pictures of colonies of Rex1-GFPd2 ES cells
cultivated in 2i or PD media and transfected with control or two independent YAP/TAZ siRNAs. Top: phase contrast images. Middle: GFP-fluorescence images
showing the activity of the Rex1-GFP reporter. Bottom: AP staining.
(C) Western blot for b-catenin, YAP, and TAZ in ES cells cultivated in 2i or PD media and transfected with the indicated siRNAs.
(D) Quantification of AP-positive colonies formed by b-catenin fl/ and b-catenin D/ ES cells transfected with control or two independent YAP/TAZ siRNAs and
cultured in PD medium. For each genotype, bars are given as percentage of the colonies formed in 2i medium and are mean + SD.
(E) Pie chart of b-catenin/TCF target genes defined as the subset of TCF3 targets previously reported by Yi et al. (2011) and induced by CH in our ES cells. Blue
area represents the fraction of b-catenin/TCF targets whose expression is under negative regulation by YAP/TAZ.
(F) qRT-PCR for the b-catenin targets Axin2 and Esrrb, normalized toGapdh expression, in ES cells transfected with control or two independent YAP/TAZ siRNAs
and cultured in PD medium. Data are referred to ES cells transfected with control siRNA and cultured in 2i medium and are presented as mean + SD.
See also Figure S6 and Table S1.only by undifferentiated ES cells (Martello et al., 2012). Thus, the
maintenance of ES cells in undifferentiated/self-renewing state
in the 2i media requires b-catenin activity, but not nuclear YAP
and TAZ responses.
These results defined a straightforward experimental setup in
which YAP/TAZ nuclear responses are ostensibly irrelevant166 Cell 158, 157–170, July 3, 2014 ª2014 Elsevier Inc.downstream of Wnt, allowing us to focus on YAP/TAZ cyto-
plasmic functions. If YAP/TAZ inhibit b-catenin at the level of
the destruction complex, then loss of YAP/TAZ should pheno-
copy GSK3 inhibition and compensate for the absence of the
GSK3 inhibitor in the ES cell medium. As shown in Figures 6B
and S6B, depletion of YAP and TAZ with two independent pairs
Figure 7. Model of How YAP/TAZ Incorpora-
tion in the b-Catenin Destruction Complex
Orchestrates the Wnt Response
A model depicting the roles of YAP/TAZ as com-
ponents of the destruction complex and b-catenin
inhibitors in the WNT OFF state (left) and as Wnt
transducers in the WNT ON state (right). See also
Discussion.of siRNAs is in fact sufficient to rescue the formation of dome-
shaped colonies of ES cells, AP positivity, and maintenance of
the reporter REX1-GFP in the otherwise differentiating PD-only
medium. These biological results are paralleled by the rescue
of endogenous b-catenin stabilization to levels comparable to
cells cultured with the GSK3 inhibitor (Figure 6C), a result consis-
tent with YAP/TAZ being relevant for the function of the destruc-
tion complex. To validate genetically that b-catenin mediates the
effect of YAP/TAZ depletion, we compared the effects of YAP/
TAZ inactivation on b-catenin fl/ (heterozygous control) versus
b-catenin null ES cells cultured in absence of GSK3 inhibitor. In
line with our prediction, YAP/TAZ knockdown partially rescued
AP staining in control, but not in b-catenin knockout cells
(Figure 6D).
Finally, we asked to what extent the transcriptional program
activated by Wnt signaling in ES cells is under negative regu-
lation by YAP/TAZ. For this, we compared the Affimetrix
gene-expression profiles of ES cells transfected with control or
anti-YAP/TAZ siRNAs and cultured either in 2i or with the PD
inhibitor alone. GSK3 inhibition is likely to have pleiotropic tran-
scriptional effects; because of this, gene sets upregulated by the
GSK3 inhibitor in control-siRNA-treated samples were filtered
according to previously identified TCF3 targets in ES cells (Yi
et al., 2011; see Experimental Procedures). These bioinformatic
analyses revealed 157 TCF/b-catenin targets confidently down-
regulated in our ES cells after removal of the GSK3 inhibitor (Ta-
ble S1). Of these, a remarkably large fraction (139 genes, 88%) is
rescued by concomitant depletion of YAP/TAZ (Figure 6E). This
set includes two of the best-characterized targets of b-catenin/
TCF targets in ES cells, Axin2 and Esrrb (Martello et al., 2012;
Yi et al., 2011). In fact, RT-PCR analysis confirmed that expres-Cell 158, 15sion of these genes is potently downregu-
lated in cells cultured in the absence of
the GSK3 inhibitor and that is rescued by
YAP/TAZ knockdown (Figure 6F). Based
on these data, we conclude that YAP/
TAZ are global inhibitors of b-catenin/TCF
transcriptional responses in mouse ES
cells.
DISCUSSION
A Framework for Wnt Signal
Transduction
The findings presented here reveal an
unexpectedly deep integration between
YAP/TAZ and the Wnt pathway (see Fig-
ure 7 for a model).We show that, in the absence of Wnt, YAP and TAZ are
components of the destruction complex to which YAP/TAZ
associate by binding to Axin1. We propose that the destruction
complex serves as cytoplasmic anchor and functional sink for
YAP/TAZ. Treatment with Wnt ligands or loss of destruction
complex components (i.e., depletion of Axin or APC) causes
rapid release of YAP/TAZ from the complex, leading to their
nuclear relocalization and activation of YAP/TAZ/TEAD-depen-
dent transcription. How does Wnt achieve this? Wnt ligands
are known to induce clustering of LRP6, in turn triggering func-
tional inactivation of the destruction complex via association of
LRP6 to Axin (Mao et al., 2001). We now found that YAP/TAZ
and LRP6 compete for the same domain of Axin to the extent
that the association of Axin to YAP/TAZ is incompatible with
Axin associating to LRP6. Thus, Axin/YAP/TAZ complexes domi-
nate in Wnt-OFF cells, whereas Axin/LRP6 complexes dominate
in Wnt-ON cells. Wnt signaling physically dislodges YAP/TAZ
from the destruction complex, causing their nuclear accumula-
tion and activation of target gene-expression.
After focusing on the destruction complex as cytoplasmic sink
for YAP/TAZ, we investigated the role of YAP/TAZ for the most
established function of the destruction complex, namely, b-cat-
enin inactivation. Here, we provide evidence that, in theWnt OFF
scenario, YAP/TAZ incorporation in the destruction complex is
essential for b-TrCP recruitment to the complex. Indeed, deple-
tion of YAP/TAZ—or forcing them in the nucleus (i.e., away from
the cytoplasmic complex)—renders the complex invisible to
b-TrCP. As such, depletion of YAP/TAZ blocks the activity of
the destruction complex against b-catenin, mimicking Wnt stim-
ulation. In other words, in Wnt ON cells, nuclear YAP/TAZ repre-
sent a branch of the Wnt transcriptional effects, whereas in the7–170, July 3, 2014 ª2014 Elsevier Inc. 167
Wnt OFF condition, cytoplasmic YAP/TAZ are effective inhibitors
of Wnt/b-catenin responses. These two functions of YAP/TAZ
stem from being integral to the destruction complex but rely on
distinct cellular states (i.e., Wnt ON versus OFF) and distinct
YAP/TAZ localizations (i.e., nuclear versus cytoplasmic). In
fact, the apparent duality of YAP/TAZ represents an elegant
mechanism by which cells make sure that Wnt signaling causes
a coherent and concomitant activation of YAP/TAZ and b-cate-
nin: YAP/TAZ nuclear localization facilitates the escape of b-cat-
enin from the destruction complex. Conversely, YAP/TAZ
nuclear exit goes hand in hand with activation of YAP/TAZ
anti-b-catenin effects.
We previously showed that the protein stability of TAZ, but not
of YAP, is regulated by phospho-b-catenin (Azzolin et al., 2012).
The present paper significantly extends those findings: on the
one hand, we show that, beyond protein stability, nuclear-
cytoplasmic shuttling of YAP and TAZ is regulated by their
sequestration in the b-catenin destruction complex. On the other
hand, we found that the association of TAZ with b-catenin also
requires an intact destruction complex, given that this associa-
tion is inhibited by Axin1/2 knockdown. Collectively, the data
suggest a unified model for YAP/TAZ regulation by the destruc-
tion complex in Wnt OFF cells: YAP and TAZ are sequestered by
the destruction complex, where they play an essential role for
phospho-b-catenin degradation by recruiting b-TrCP (Figure 7).
In the reciprocal direction, the destruction complex brings about
the phospho-b-catenin/TAZ/b-TrCP association that leads to
TAZ degradation (Figure 1B and Azzolin et al., 2012). Thus, it is
the concomitant presence of YAP/TAZ and phospho-b-catenin
within the complex that allows b-TrCP recruitment with ensuing
TAZ and b-catenin inhibition.
YAP/TAZ and the Wnt Outcome
In light of the present work, YAP/TAZ may regulate the potent
biological effects of Wnt signaling both positively and negatively,
also depending on the relative relevance of the Wnt/b-catenin/
TCF and Wnt/YAP/TAZ transcriptional programs for the execu-
tion of the Wnt biological response. In this respect, we can
envision three prototypic scenarios in which Wnt responses
are realized by (1) TCF/b-catenin, (2) YAP/TAZ, and (3) both
b-catenin and YAP/TAZ.
In the first scenario, YAP/TAZ transcriptional responses are
irrelevant for the Wnt response, and b-catenin inactivation in
the cytoplasm is the only important function of YAP/TAZ. The
self-renewal of ES cells cultured in the 2i media represents
such a paradigm. YAP/TAZ inactivation in ES cells can by itself
compensate for loss of Wnt signaling, sustaining b-catenin-
dependent gene expression and suppressing ES cell differentia-
tion. YAP/TAZ are often portrayed as general ‘‘stemness’’
factors. A previous report suggested a positive role of YAP for
the undifferentiated state of ES cells cultured in LIF (Lian et al.,
2010); yet, our data do not support this conclusion in cells
cultured in fully defined 2i medium.
In the second scenario, nuclear YAP/TAZ transcriptional
responses, rather than b-catenin/TCF, may serve as primary
mediators of the effects of Wnt signaling. A paradigm for such
scenario is the Wnt-dependent differentiation of mesenchymal
stem cells into bone. Although mouse genetics indicate a role168 Cell 158, 157–170, July 3, 2014 ª2014 Elsevier Inc.for canonical Wnt signaling in bone differentiation, it has been re-
ported that b-catenin deletion fails to recapitulate the phenotype
of LRP5mutants, indicating the involvement of factors other than
b-catenin downstream of Wnt (Baron and Kneissel, 2013). We
previously showed that TAZ mediates this phenotype (Azzolin
et al., 2012). Moreover, we could extend such a requirement
for YAP during Wnt-induced bone differentiation of ST-2 mesen-
chymal progenitor cells (L.A. and S.P., unpublished data).
In the third scenario, both YAP/TAZ- and b-catenin/TCF-
dependent gene expression programs are essential to attain
the full panel ofWnt-regulated biological effects. We have genet-
ically validated this scenario in the biology of intestinal crypts for
which the role of b-catenin/TCF is already well established
(Clevers, 2006). APC inactivation in conditional knockout mice
is a paradigmmodel system to study the effects of Wnt signaling
on the expansion of progenitor cells (Sansom et al., 2004). Here,
we show that YAP/TAZ are remarkably essential for this pheno-
type: APC/YAP/TAZ triple knockouts display ostensibly normal
crypts and villi, overcoming the rapid demise of mice with the
sole APC deficiency. Intriguingly, this rescue occurs in spite of
an underlying aberrant activation of Wnt/b-catenin-dependent
transcription, as visualized in triple mutants by ectopic LEF1 or
CD44 expression throughout the crypt-villus axis, to levels
comparable to those seen in APC knockouts. This reinforces
the notion that b-catenin and YAP/TAZ nuclear programs must
necessarily complement each other in the context of intestinal
crypt overgrowth induced by the inactivation of the destruction
complex. Development of intestinal ‘‘organoids’’ in vitro is known
to require the Wnt-agonist R-Spondin (de Lau et al., 2011). Here,
we genetically validated the requirement of YAP/TAZ for intesti-
nal crypt outgrowth ex vivo and found that YAP and TAZ are
essential for the expansion and survival of explanted intestinal
crypts, phenocopying the effect of LGR4/5 knockouts (i.e., the
R-spondin receptors).
In light of these results, it is worth discussing the apparent lack
of YAP/TAZ relevance for normal intestinal homeostasis. It is
possible that b-catenin and the YAP/TAZ transcriptional pro-
gramsmay carry out an effective ‘‘division of labor’’ downstream
of Wnt signaling, with b-catenin/TCF controlling normal homeo-
stasis and YAP/TAZ playing a more dominant role in conditions
characterized by intense intestinal proliferation, such as during
APC deficiency, tumorigenesis, regeneration, or ex vivo crypt re-
growth (reviewed in Cordero and Sansom, 2012). In line with this
interpretation, YAP has been shown to be essential in some
regenerative contexts, such as intestinal recovery after inflam-
matory damage (Cai et al., 2010).
Cross-Regulations
We further note that nuclear YAP/TAZ may trigger ‘‘Wnt’’
signaling—perhaps even in the absence of Wnt ligands or by
cooperating with subeffective amounts of surrounding Wnts.
For example, a general bias in considering intestinal crypt
biology is the assumption that Wnt ligands are the upstream
inducers of b-catenin signaling. However, evidence in this direc-
tion is surprisingly scant (San Roman et al., 2014). Notably,
nuclear YAP/TAZ accumulation can be induced by tissue archi-
tectural cues and mechanotransduction (Aragona et al., 2013;
Dupont et al., 2011). Intriguingly, computational modeling
studies predicted that the crypt’s own 3D architecture and
mechanical forces are the key ingredients for crypt biology and
self-organizing properties (Buske et al., 2012); in fact, biome-
chanical parameters—such as the curvature of the basal mem-
brane and dynamic cell shape changes at the crypt bottom—
may trigger YAP/TAZ nuclear localization along with a b-catenin
response (Figure 7). Clearly, further work is required to expand
on these ideas. Irrespective of the nature of the upstream signals
that regulate YAP/TAZ localization, both YAP and TAZ are nu-
clear in intestinal crypt cells. The lack of phenotype in YAP/
TAZ intestinal knockouts during normal tissue homeostasis
suggests that endogenous YAP/TAZ nuclear localization at the
bottom of the intestinal crypts may simply represent a mean to
remove YAP/TAZ from the cytoplasm to prevent their anti-b-cat-
enin effects. In this view, asmuch as YAP/TAZ cytoplasmic local-
ization represents an inhibition of their transcriptional responses,
their nuclear localization may represent a relief from their anti-
Wnt effects. If, during normal intestinal homeostasis, YAP/TAZ
are already inhibited by ‘‘nuclear sequestration’’ in crypt cells,
this might explain why their genetic ablation is inconsequential
for normal physiology. Although speculative, this scenario might
explain why overexpression of a cytoplasmic and transcription-
ally defective version of YAP can rapidly terminateWnt signaling,
turn off b-catenin/TCF targets, and cause crypt degeneration in
transgenic mice (Barry et al., 2013).
The Hippo pathway is another pillar of YAP/TAZ regulation. In
the heart, knockout of the Hippo pathway components Salvador
and MST1/2 also turns on nuclear b-catenin localization and
activation of Wnt-target genes, including some that are under
joined control of b-catenin/TCF and YAP/TAZ/TEAD responsive
promoter elements (Heallen et al., 2011). Crucially, b-catenin is
genetically required for heart overgrowth induced by Hippo
pathway deficiencies. How can b-catenin escape the strict
control of the destruction complex when the Hippo cascade is
turned off? The model described in Figure 7 accommodates
these findings. Inactivation of the Hippo pathway would facilitate
YAP/TAZ nuclear activities, diverting them away from the cyto-
plasmic destruction complex; as a result, b-catenin is no longer
inactivated, with loss of Hippo signaling de facto turning on Wnt
signaling. Although there is currently no evidence that the activity
of Hippo kinases is patterned in living tissues, YAP/TAZ nuclear
versus cytoplasmic localization by the Hippo pathway might
modify the thresholds of theWnt/YAP/TAZ and of theWnt/b-cat-
enin responses.
Prior to this study, Varelas et al. (2010) suggested that the
Hippo pathway might attenuate Wnt/b-catenin signaling and
that this correlated with TAZ-mediated regulation of Dvl phos-
phorylation by CK1. The functional relevance of Dvl phosphory-
lation in the context of Wnt signaling remains unclear; in any
case, Dvl phosphorylation is known to occur independently
from the destruction complex (Gonzalez-Sancho et al., 2013).
This suggests that the Dvl regulatory layer may act in Wnt ON
cells in parallel to the anti-b-catenin effects of cytoplasmic
YAP/TAZ at the level of the destruction complex here described.
Finding that YAP/TAZ inactivation is detrimental for prolifera-
tion and self-renewal of cells modified by aberrant, oncogenic
Wnt signaling—but not for normal stem cells—has implications
in the cancer field. YAP/TAZ activation is frequent in humantumors; our data at least suggest that, in adult organs, YAP/
TAZ may be at the heart of a genetic program of tissue regener-
ation normally inactive during normal tissue replenishment but
locked in an ON state for tumor growth. For example, this may
expand cells with stem cells characteristics (Cordenonsi et al.,
2011). In this view, only self-renewal and proliferation of the
tumor tissue, but not those of its corresponding normal tissue,
would be addicted to YAP/TAZ; as such, YAP/TAZ and its
upstream regulators may represent prime targets to develop
more effective and less toxic cancer therapies.
EXPERIMENTAL PROCEDURES
Monitoring Wnt Effects on YAP/TAZ
For immunofluorescence in HEK293 cells, P19 cells and ST-2 cells were plated
at 100% confluency on fibronectin-coated chamberslides (Nunc). After 24 hr,
culturedmediumwas changed tomedium containingWnt3A (R&D, 100 ng/ml).
Treatment lasted 8 hr before fixation with PFA 4%. For transfected MII cells,
these were plated at 20% confluency and then transfected with siRNAs, and
the next day, they were plated at very high density on fibronectin-coated
chamberslides; cells were fixed after 48 hr. Immunofluorescence was as
described in Cordenonsi et al. (2011) using anti-YAP (H-9 sc-271134; 1:200,
blocking in goat serum; monoclonal antibody was from Santa Cruz) and
anti-TAZ (560235; 1:100, blocking in BSA; monoclonal antibody was from
BD Bioscience).
For the luciferase assay, cells were plated at 25% confluence (day 0) and the
next day (day 1) were transfected with DNA. At day 2, cells were washed from
DNA-transfection medium and harvested after 24 hr (day 3). For luciferase
assays in siRNA-depleted cells, cells were plated at 20% confluence (day 0),
and the next day (day 1), they were transfected with the indicated siRNAs
for nomore than 8 hr before changingmedium. At day 2, cells were transfected
with DNA, at day 3, the medium was changed, and cells were harvested at day
4. Where indicated, cells were treated with recombinant Wnt3A (R&D; final
concentration 100 ng/ml) for 8 hr before harvesting, unless otherwise specified
(i.e., Figure 2E). Each sample was transfected in duplicate, and each experi-
ment was repeated at least three times independently. siRNA sequences are
listed in Table S2.
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